Predictive modeling for dystrophin accumulation that includes assumptions of known turnover of dystrophin in the muscle and an analysis of data generated with the PPMO platform indicates that SRP5051 at 30 mgkg is likely to deliver greater than 10 dystrophin over time with monthly dosing